RELATED STUDY

The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders


Key Findings:  The authors highlight the role the eCBome plays in the microbiota-gut-brain axis and its association with affective and cognitive functions and in their pathological alterations in neuropsychiatric disorders.
 In addition, the review focuses on eCBome-based drugs beyond that of THC including CBD, which possess a wide therapeutic window.